In-office urine drug screen usage, frequency, and billing has increasingly been a target of recent government audits, investigations, and fraud penalties.
Just by offering urine drug screens puts you at the top federal investigator and auditor radars, even if you’ve done nothing wrong. But, if you know what the red flags are, you can avoid getting targeted.
You can continue to offer these essential tests without the worry of legal and financial penalties, and healthcare attorney, Edgar D. Bueno, JD, can help. During his 60-minute online training session, he’ll walk you through how to avoid in-office drug testing mistakes that will land in you in legal trouble with the Feds.
Here are just a few of the practical, plain-English in-office urine drug screening compliance tactics you’ll receive by viewing this 60-minute online training session:
- Master frequency guidelines to avoid landing on audit radars
- Reduce claim denials with specific “patient focused” test ordering guidelines
- Respond to government audit requests correctly and head off additional charges
- How to make Federal Opioid Treatment Standards work for you
- Master the terminology (i.e. “qualitative vs. quantitative”) to help you choose the right code
- Accurately determine when it’s time to hire an outside consultant
- Adopt proven coding and billing tactics to boost pay up
- Improve laboratory contracts to stop the Feds from nosing around
- And much, much more…
Who should attend: If your practice provides in-office urine drug testing this session is a must-attend.
Added Bonus: You’ll receive an inside look at recent case examples and settlements so you can avoid the mistakes these practices made.
By viewing this online training you’ll receive a step-by-step breakdown of how you can more accurately, effectively and efficiently comply with Federal requirements when providing urine drug testing.
Edgar D. Bueno is a Partner with the law firm of Morris, Manning & Martin, LLP in Atlanta. He has over 20 years of experience with healthcare fraud and abuse matters.
He regularly defends providers, laboratories, and pharmacies in civil and criminal investigations and audits, including those involving billing for urine drug screens. He has successfully represented clients before numerous government agencies including the Centers for Medicare & Medicaid Services, TRICARE, U.S. Department of Justice, Office of Inspector General for the Department of Health & Human Services, Drug Enforcement Administration, state licensing boards, and state law enforcement authorities.
His prior experience includes serving as an Assistant United States Attorney for the Department of Justice and an enforcement attorney for the U.S Department of Health & Human Services, Office of Inspector General.
Very pleasant and presenter was well spoken. He covered the subject, wish there had been more on documentation.
Very informative, he allowed for a decent amount of time and answered questions that everyone had.
This webinar was a positive experience. The information was very helpful to compare to our present Pain Management Policy for UDS testing and found areas we could critique to show we truly are in compliance.
Thought the slides were great and the follow-up questions were handled well.
The section covering red flags was also beneficial.